title: Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.
abstract: Chronic hepatitis B is a major health problem in China. The universal vaccination program since 1992 has changed the epidemiology of hepatitis B virus infection in China from highly to moderately endemic. The most prevalent hepatitis B virus strains in China are genotypes B and C, whereas those in western provinces are genotypes D and C/D hybrid. Chronic hepatitis B poses a heavy burden to the society in China. Different treatment strategies have been explored to improve patient outcomes in a cost-effective manner. However, antiviral drugs with a low genetic barrier to resistance are still extensively used because of the generally low income and limited resources in China. Individualized antiviral therapy is closely associated with translational medicine, which utilizes information from studies on genomics, immune biomarkers, and fibrosis. The results of these studies are crucial in further improving treatment outcomes.
authors.affiliation: Hepatology Unit and Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
authors.forename: Rui
authors.initials: R
authors.lastname: Yu
authors.forename: Rong
authors.initials: R
authors.lastname: Fan
authors.forename: Jinlin
authors.initials: J
authors.lastname: Hou
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D005838:Genotype; D006515:Hepatitis B virus / Q000235:genetics; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D015995:Prevalence
chemical_list: D000998:Antiviral Agents